Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 8, 2008 - Issue 9
Submit an article Journal homepage
161
Views
12
CrossRef citations to date
0
Altmetric
Drug Profile

Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utility

Seetal Dodd Department of Clinical & Biomedical Sciences, University of Melbourne, Geelong, Australia. [email protected]
&
Michael Berk Orygen Research Centre; Mental Health Research Institute, Parkville, Australia; Department of Clinical & Biomedical Sciences, University of Melbourne, Geelong, Australia
Pages 1299-1306 | Published online: 09 Jan 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shuxin Luan, Hongquan Wan, Shijun Wang, He Li & Baogang Zhang. (2017) Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials. Neuropsychiatric Disease and Treatment 13, pages 609-620.
Read now
William V Bobo & Richard C Shelton. (2009) Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues. Neuropsychiatric Disease and Treatment 5, pages 369-383.
Read now

Articles from other publishers (10)

Anna K. Drabczyk, Damian Kułaga, Przemysław Zaręba, Wiktoria Tylińska, Wojciech Bachowski, Aneta Archała, Artur Wnorowski, Andromachi Tzani, Anastasia Detsi & Jolanta Jaśkowska. (2023) Eco-friendly synthesis of new olanzapine derivatives and evaluation of their anticancer potential. RSC Advances 13:30, pages 20467-20476.
Crossref
José V. Pardo, Sohail A. Sheikh, Graeme Schwindt, Joel T. Lee, David E. Adson, Barry Rittberg & Faruk S. Abuzzahab. (2020) A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination. PLOS ONE 15:1, pages e0226486.
Crossref
Laura Schulze, Gary Remington, Peter Giacobbe, Sidney H Kennedy, Daniel M Blumberger, Zafiris J Daskalakis & Jonathan Downar. (2016) Effect of antipsychotic pharmacotherapy on clinical outcomes of intermittent theta-burst stimulation for refractory depression. Journal of Psychopharmacology 31:3, pages 312-319.
Crossref
A. L. D’yakonov & I. V. Lobanova. (2014) Comparative Studies of the Efficacy of Combinations of SSRI Antidepressants and Antipsychotics in the Treatment of Recurrent Depressive Disorder. Neuroscience and Behavioral Physiology 44:2, pages 195-199.
Crossref
Azam Bakhtiarian, Nasrin Takzare, Mehdi Sheykhi, Narges Sistany, Farahnaz Jazaeri, Mario Giorgi & Vahid Nikoui. (2014) Teratogenic Effects of Coadministration of Fluoxetine and Olanzapine on Rat Fetuses. Advances in Pharmacological Sciences 2014, pages 1-6.
Crossref
Thomas C. Baghai, Pierre Blier, David S. Baldwin, Michael Bauer, Guy M. Goodwin, Kostas N. Fountoulakis, Siegfried Kasper, Brian E. Leonard, Ulrik F. Malt, Dan Stein, Marcio Versiani & Hans-Jürgen Möller. (2011) General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience 261:S3, pages 207-245.
Crossref
Anders S. Kristensen, Jacob Andersen, Trine N. Jørgensen, Lena Sørensen, Jacob Eriksen, Claus J. Loland, Kristian Strømgaard & Ulrik Gether. (2011) SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation. Pharmacological Reviews 63:3, pages 585-640.
Crossref
Frederick W. Reimherr, Michael L. Martin, James M. Eudicone, Barrie K. Marchant, Quynh-Van Tran, Andrei Pikalov, Ronald N. Marcus, Robert M. Berman & Berit X. Carlson. (2010) A Pooled MADRS/IDS Cross-Correlation Analysis. Journal of Clinical Psychopharmacology 30:3, pages 300-305.
Crossref
Claire Z Larter, Shiv Chitturi, Déborah Heydet & Geoffrey C Farrell. (2010) A fresh look at NASH pathogenesis. Part 1: The metabolic movers. Journal of Gastroenterology and Hepatology 25:4, pages 672-690.
Crossref
Jamie D. Croxtall & Lesley J. Scott. (2010) Olanzapine/Fluoxetine. CNS Drugs 24:3, pages 245-262.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.